Investigating Genetic Status in Patients Presenting to Clinic

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

The causes of neurodegenerative dementias such as Frontotemporal Dementia, Lewy Body Disease and Alzheimer's disease are still largely unknown. While the contribution of some genetic mutations and polymorphisms is associated with autosomal dominant patterns of inheritance of these dementias, in many cases, the specific causative mutation in these families is not yet identified. Further, in many patients, polygenic risk is thought to give rise to pathophysiologic changes, but which specific genes affect risk are largely yet unknown. By examining genotypes in patients that present to our Cognitive Neurology and Alzheimer's Research Clinic with suspected or confirmed neurodegenerative dementia, or have a history of a familial dementia, we aim to help identify and characterize genetic mutations or polymorphisms that give rise to neurodegenerative diseases.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Persons presenting to the cognitive clinic with a neurodegenerative disorder (for example, AD, FTD, LBD, ALSP, and related conditions);

Biological family members of someone diagnosed with a neurodegenerative disorder, presenting to clinic;

Age 18+ years old;

Consenting to a blood draw.

Disqualifiers

None

Trial population

Persons presenting to the cognitive clinic with a neurodegenerative disorder (for example, AD, FTD, LBD, ALSP, and related conditions); Biological family members of someone diagnosed with a neurodegenerative disorder, presenting to clinic;

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Biosample collection.

    Other intervention

    Blood draw.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Blood draw for genetic status or polymorphism result.

The blood draw is taken at the time of the clinic visit. Up to 30ml will be collected by standard venipuncture.

Time frame
A one-time visit, taking the participant approximately 20 minutes total for all study procedures.

Secondary outcomes

1

Demographic information.

Demographic information will be collected at the time of the clinic visit.

Time frame
A one-time visit, taking the participant approximately 20 minutes total for all study procedures.
2

Medical history/Clinical diagnoses.

Will be obtained via chart review when available. This information is collected already as part of the patient's standard care.

Time frame
Typically within 1 month of the clinic visit, taking approximately 5 minutes.
3

Pathological diagnoses.

Will be obtained via chart review when available. This information is collected already as part of the patient's standard care.

Time frame
Typically within 1 month of the clinic visit, taking approximately 5 minutes.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.